|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/454 | |
| A61K 31/282 | |||
| A61K 31/357 | |||
| A61K 31/366 | |||
| A61K 31/4035 | |||
| A61K 31/541 | |||
| A61K 31/7068 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2521543 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11700288.1 |
| Europos patento paraiškos padavimo data | 2011-01-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-04-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/020160 |
| Data | 2011-01-05 |
| (87) | Numeris | WO 2011/084968 |
| Data | 2011-07-14 |
| (30) | Numeris | Data | Šalis |
| 371347 P | 2010-08-06 | US | |
| 292307 P | 2010-01-05 | US |
| (72) |
DALGLEISH, Angus, GB
GRAVETT, Andrew, GB
LIU, Wai, GB
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | A COMBINATION OF AN IMMUNOMODULATORY COMPOUND AND AN ARTEMISININ DERIVATIVE FOR TREATING CANCER |
| A COMBINATION OF AN IMMUNOMODULATORY COMPOUND AND AN ARTEMISININ DERIVATIVE FOR TREATING CANCER |